Skip to main content
. 2021 Jan 31;12(1):507–515. doi: 10.1080/21655979.2021.1880060

Figure 2.

Figure 2.

Inhibition of PI3K or mTOR reduced ligustrazine-mediated protection of RGCs after I/R injury. RGCs with retinal I/R injury were treated with 10 μg/mL ligustrazine alone or with 10 µM Ly294002 or 10 μM rapamycin. **p< 0.01 vs. normal group; ##p< 0.01 vs. model group. $$p< 0.01 vs. ligustrazine group